Efficacy and Safety Study of Niraparib in Melanoma With Genetic Homologous Recombination (HR) Mutation

Condition:   Metastatic Melanoma
Intervention:   Drug: Niraparib
Sponsors:   California Pacific Medical Center Research Institute;   Mt. Sinai Medical Center, Miami;   Tesaro, Inc.
Recruiting
ClinicalTrials.gov: Genetic_Disease | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days